PortfoliosLab logoPortfoliosLab logo
GLSI vs. QNRX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

GLSI vs. QNRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Greenwich LifeSciences, Inc. (GLSI) and Quoin Pharmaceuticals Ltd DRC (QNRX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GLSI achieves a -11.61% return, which is significantly higher than QNRX's -70.69% return.


GLSI

1D
-6.21%
1M
-22.82%
6M
-30.79%
YTD
-11.61%
1Y
71.31%
3Y*
25.74%
5Y*
-15.06%
10Y*

QNRX

1D
-4.94%
1M
0.71%
6M
-63.90%
YTD
-70.69%
1Y
-52.42%
3Y*
-73.80%
5Y*
-86.24%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

GLSI vs. QNRX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
GLSI
Greenwich LifeSciences, Inc.
-11.61%87.09%6.75%-30.79%-37.53%-33.29%534.26%
QNRX
Quoin Pharmaceuticals Ltd DRC
-70.69%-36.64%-86.73%-71.21%-93.76%-78.94%-13.25%

Correlation

The correlation between GLSI and QNRX is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.04

Correlation (3Y)
Calculated over the trailing 3-year period

0.06

Correlation (5Y)
Calculated over the trailing 5-year period

0.11

Correlation (All Time)
Calculated using the full available price history since Sep 25, 2020

0.11

Fundamentals

Market Cap

GLSI:

$272.57M

QNRX:

$8.49M

EPS

GLSI:

-$1.56

QNRX:

-$11.36

PB Ratio

GLSI:

51.32

QNRX:

1.36

Total Revenue (TTM)

GLSI:

$3.56K

QNRX:

$0.00

Gross Profit (TTM)

GLSI:

$903.00

QNRX:

-$24.93K

EBITDA (TTM)

GLSI:

-$21.89M

QNRX:

-$17.28M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GLSI vs. QNRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GLSI
GLSI Risk / Return Rank: 7272
Overall Rank
GLSI Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
GLSI Sortino Ratio Rank: 7373
Sortino Ratio Rank
GLSI Omega Ratio Rank: 7070
Omega Ratio Rank
GLSI Calmar Ratio Rank: 7474
Calmar Ratio Rank
GLSI Martin Ratio Rank: 7272
Martin Ratio Rank

QNRX
QNRX Risk / Return Rank: 3636
Overall Rank
QNRX Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
QNRX Sortino Ratio Rank: 5252
Sortino Ratio Rank
QNRX Omega Ratio Rank: 5151
Omega Ratio Rank
QNRX Calmar Ratio Rank: 2222
Calmar Ratio Rank
QNRX Martin Ratio Rank: 2424
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GLSI vs. QNRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Greenwich LifeSciences, Inc. (GLSI) and Quoin Pharmaceuticals Ltd DRC (QNRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GLSIQNRXDifference
Sharpe ratioReturn per unit of total volatility

+1.01

Sortino ratioReturn per unit of downside risk

+0.98

Omega ratioGain probability vs. loss probability

1.19

1.09

+0.11

Calmar ratioReturn relative to maximum drawdown

1.58

-0.62

+2.19

Martin ratioReturn relative to average drawdown

3.14

-0.98

+4.12

GLSI vs. QNRX - Sharpe Ratio Comparison

The current GLSI Sharpe Ratio is 0.74, which is higher than the QNRX Sharpe Ratio of -0.27. The chart below compares the historical Sharpe Ratios of GLSI and QNRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

GLSI vs. QNRX - Drawdown Comparison

The maximum GLSI drawdown since its inception was -90.11%, smaller than the maximum QNRX drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for GLSI and QNRX.


Loading charts...

Drawdown Indicators


GLSIQNRXDifference

Max Drawdown

Largest peak-to-trough decline

-90.11%

-100.00%

+9.89%

Max Drawdown (1Y)

Largest decline over 1 year

-45.39%

-85.43%

+40.04%

Max Drawdown (3Y)

Largest decline over 3 years

-61.37%

-98.98%

+37.61%

Max Drawdown (5Y)

Largest decline over 5 years

-84.52%

-100.00%

+15.48%

Current Drawdown

Current decline from peak

-74.29%

-100.00%

+25.71%

Average Drawdown

Average peak-to-trough decline

-72.74%

-81.63%

+8.89%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.76%

53.46%

-30.70%

Volatility

GLSI vs. QNRX - Volatility Comparison

The current volatility for Greenwich LifeSciences, Inc. (GLSI) is 31.33%, while Quoin Pharmaceuticals Ltd DRC (QNRX) has a volatility of 43.19%. This indicates that GLSI experiences smaller price fluctuations and is considered to be less risky than QNRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GLSIQNRXDifference

Volatility (1M)

Calculated over the trailing 1-month period

31.33%

43.19%

-11.86%

Volatility (6M)

Calculated over the trailing 6-month period

74.38%

70.57%

+3.81%

Volatility (1Y)

Calculated over the trailing 1-year period

97.03%

193.31%

-96.28%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

79.37%

214.10%

-134.73%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

424.83%

172.19%

+252.64%

Dividends

GLSI vs. QNRX - Dividend Comparison

Neither GLSI nor QNRX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

GLSI vs. QNRX - Financials Comparison

This section allows you to compare key financial metrics between Greenwich LifeSciences, Inc. and Quoin Pharmaceuticals Ltd DRC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00K2.00K3.00K4.00KJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober202600
(GLSI) Total Revenue
(QNRX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


GLSI and QNRX have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

QNRX has higher volatility (43.19%) compared to GLSI (31.33%). In terms of maximum drawdown, GLSI dropped -90.11% vs QNRX's -100.00%.

GLSI currently has the higher Sharpe Ratio (0.74 vs -0.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GLSI and QNRX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer